Antonio LA MARCA
Antonio LA MARCA
Professor of Obstetrics and Gynecology at the University of Modena and Reggio Emilia, Modena, Italy
Verified email at - Homepage
Cited by
Cited by
ESHRE consensus on the definition of ‘poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
AP Ferraretti, A La Marca, B Fauser, B Tarlatzis, G Nargund, L Gianaroli, ...
Human reproduction 26 (7), 1616-1624, 2011
Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
A La Marca, G Sighinolfi, D Radi, C Argento, E Baraldi, AC Artenisio, ...
Human reproduction update 16 (2), 113-130, 2010
The physiology and clinical utility of anti-Müllerian hormone in women
D Dewailly, CY Andersen, A Balen, F Broekmans, N Dilaver, R Fanchin, ...
Human reproduction update 20 (3), 370-385, 2014
Serum anti-Mullerian hormone throughout the human menstrual cycle
A La Marca, G Stabile, AC Artenisio, A Volpe
Human reproduction 21 (12), 3103-3107, 2006
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice
A La Marca, SK Sunkara
Human reproduction update 20 (1), 124-140, 2014
Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach
SL Broer, J van Disseldorp, KA Broeze, M Dolleman, BC Opmeer, ...
Human reproduction update 19 (1), 26-36, 2013
Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology
A La Marca, S Giulini, A Tirelli, E Bertucci, T Marsella, S Xella, A Volpe
Human reproduction 22 (3), 766-771, 2007
Anti-Müllerian hormone (AMH): what do we still need to know?
A La Marca, FJ Broekmans, A Volpe, BC Fauser, NS Macklon
Human reproduction 24 (9), 2264-2275, 2009
Anti‐Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?
A La Marca, A Volpe
Clinical endocrinology 64 (6), 603-610, 2006
Insulin-lowering agents in the management of polycystic ovary syndrome
V De Leo, A La Marca, F Petraglia
Endocrine reviews 24 (5), 633-667, 2003
Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays
A La Marca, M Capuzzo, T Paglia, L Roli, T Trenti, SM Nelson
Reproductive biomedicine online 41 (3), 483-499, 2020
Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome
V De Leo, A La Marca, A Ditto, G Morgante, A Cianci
Fertility and sterility 72 (2), 282-285, 1999
Insulin-dependent diabetes in men is associated with hypothalamo-pituitary derangement and with impairment in semen quality
B Baccetti, A La Marca, P Piomboni, S Capitani, E Bruni, F Petraglia, ...
Human Reproduction 17 (10), 2673-2677, 2002
LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling
L Casarini, M Lispi, S Longobardi, F Milosa, A La Marca, D Tagliasacchi, ...
Public Library of Science 7 (10), e46682, 2012
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial
A Nyboe Andersen, SM Nelson, BCJM Fauser, JA García-Velasco, ...
Fertility and Sterility 107 (2), 387-396. e4, 2017
Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation
A La Marca, S Malmusi, S Giulini, LF Tamaro, R Orvieto, P Levratti, ...
Human Reproduction 19 (12), 2738-2741, 2004
ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ‘poor response’to ovarian stimulation for in vitro fertilization: the Bologna criteria
AP Ferraretti, A La Marca, BC Fauser, B Tarlatzis, G Nargund, L Gianaroli
Hum Reprod 26 (7), 1616-1624, 2011
Hormonal effects of flutamide in young women with polycystic ovary syndrome
V De Leo, D Lanzetta, D D’Antona, A La Marca, G Morgante
The Journal of Clinical Endocrinology & Metabolism 83 (1), 99-102, 1998
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients
JC Arce, A La Marca, BM Klein, AN Andersen, R Fleming
Fertility and sterility 99 (6), 1644-1653. e1, 2013
Anti-Müllerian hormone concentrations in maternal serum during pregnancy
A La Marca, S Giulini, R Orvieto, V De Leo, A Volpe
Human reproduction 20 (6), 1569-1572, 2005
The system can't perform the operation now. Try again later.
Articles 1–20